BR112014025823A8 - Parasitas plasmodium de roedores utilizados como plataformas para uma vacina contra a malária á base de organismos inteiros - Google Patents

Parasitas plasmodium de roedores utilizados como plataformas para uma vacina contra a malária á base de organismos inteiros

Info

Publication number
BR112014025823A8
BR112014025823A8 BR112014025823A BR112014025823A BR112014025823A8 BR 112014025823 A8 BR112014025823 A8 BR 112014025823A8 BR 112014025823 A BR112014025823 A BR 112014025823A BR 112014025823 A BR112014025823 A BR 112014025823A BR 112014025823 A8 BR112014025823 A8 BR 112014025823A8
Authority
BR
Brazil
Prior art keywords
rodent plasmodium
platforms
organisms
plasmodium
rodent
Prior art date
Application number
BR112014025823A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112014025823A2 (https=
Inventor
Miguel Prudêncio Pignatelli Rui
Manuel Dias Da Mota Maria
Manuel Barbeiro Mendes Antônio
Original Assignee
Inst De Medicina Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst De Medicina Molecular filed Critical Inst De Medicina Molecular
Publication of BR112014025823A2 publication Critical patent/BR112014025823A2/pt
Publication of BR112014025823A8 publication Critical patent/BR112014025823A8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112014025823A 2012-04-17 2013-04-17 Parasitas plasmodium de roedores utilizados como plataformas para uma vacina contra a malária á base de organismos inteiros BR112014025823A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT10626212 2012-04-17
PCT/IB2013/053050 WO2013156949A1 (en) 2012-04-17 2013-04-17 Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine

Publications (2)

Publication Number Publication Date
BR112014025823A2 BR112014025823A2 (https=) 2017-06-20
BR112014025823A8 true BR112014025823A8 (pt) 2017-07-25

Family

ID=48539330

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014025823A BR112014025823A8 (pt) 2012-04-17 2013-04-17 Parasitas plasmodium de roedores utilizados como plataformas para uma vacina contra a malária á base de organismos inteiros

Country Status (10)

Country Link
US (1) US9655957B2 (https=)
EP (1) EP2838554B1 (https=)
JP (1) JP6096884B2 (https=)
CN (1) CN104302313B (https=)
AU (1) AU2013250814B2 (https=)
BR (1) BR112014025823A8 (https=)
IN (1) IN2014MN02275A (https=)
PT (1) PT2838554T (https=)
WO (1) WO2013156949A1 (https=)
ZA (1) ZA201408440B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104771752B (zh) * 2015-04-21 2018-01-05 中国人民解放军第三军医大学 疟疾红内期灭活全虫疫苗的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2551193C (en) * 2003-12-19 2011-02-01 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2978048B1 (fr) * 2011-07-20 2014-10-10 Univ Paris Curie Composition vaccinale contre le paludisme

Also Published As

Publication number Publication date
EP2838554A1 (en) 2015-02-25
IN2014MN02275A (https=) 2015-08-07
JP6096884B2 (ja) 2017-03-15
PT2838554T (pt) 2018-11-23
AU2013250814A1 (en) 2014-12-04
CN104302313A (zh) 2015-01-21
US9655957B2 (en) 2017-05-23
AU2013250814B2 (en) 2017-03-02
US20150071966A1 (en) 2015-03-12
ZA201408440B (en) 2015-12-23
EP2838554B1 (en) 2018-08-22
JP2015514745A (ja) 2015-05-21
CN104302313B (zh) 2018-01-26
WO2013156949A1 (en) 2013-10-24
HK1206243A1 (en) 2016-01-08
BR112014025823A2 (https=) 2017-06-20

Similar Documents

Publication Publication Date Title
CY1122824T1 (el) Πρωτεϊνες συντηξης και εμβολια συνδυασμου
UY32874A (es) Compuestos y composiciones como moduladores de la actividad de tlr
DK2459216T3 (da) Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer
MX391015B (es) Composiciones de nanoparticulas y usos de las mismas
MX386142B (es) COMPOSICIONES INMUNOGÉNICAS PARA EL CORONAVIRUS DEL SÍNDROME RESPIRATORIO DE ORIENTE MEDIO (MERS-CoV) Y SUS USOS.
CY1122483T1 (el) Λυοφιλοποιημενες παρασκευες μελφαλανης φλουφεναμιδης
BR112017001310A2 (pt) coronavírus
MX2021008224A (es) Combinacion de vacunacion e inhibicion de la trayectoria pd-1.
MX2016013149A (es) Produccion de celulas t modificadas, mediante transposon bella durmiente, acoplada con seleccion por metotrexato.
MX2015001871A (es) Celulas asesinas naturales y usos de las mismas.
SMT201600406B (it) Derivati della 8-carbamoil-2-(pirid-6-il-2,3-disostituito)-1,2,3,4-tetraidroisochinolina come agenti inducenti apoptosi per il trattamento del cancro e di malattie immunitarie e autoimmunitarie
EA201790109A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
UY33297A (es) Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas
EA201391515A1 (ru) Инактивированная вакцина вируса денге
CY1126231T1 (el) Παραλλαγες ανθρωπινης αλφα-γαλακτοσιδασης
MX381497B (es) Composiciones vacuna.
CR20140069A (es) Formulaciones parenterales de vacunas contra los norovirus
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
GT201500005A (es) Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue
UY32457A (es) Vacuna del virus del dengue inactivado
CL2014001060A1 (es) Compuestos derivados de aril-quinolina; proceso de obtencion; composicion farmaceutica que los comprende y uso en el tratamiento o profilaxis de la diabetes tipo 2, la aterosclerosis, cancer, entre otras enfermedades.
MA37749A1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
MX2015007573A (es) Vacuna contra el tumor de wilms 1.
CY1121859T1 (el) Μεθοδος παρασκευης αναστολεων συνθασης γλυκοζυλοκεραμιδης

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]